These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23359313)

  • 1. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.
    Davila JA; Kramer JR; Duan Z; Richardson PA; Tyson GL; Sada YH; Kanwal F; El-Serag HB
    Hepatology; 2013 May; 57(5):1858-68. PubMed ID: 23359313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
    Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
    Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.
    Hyder O; Dodson RM; Nathan H; Herman JM; Cosgrove D; Kamel I; Geschwind JF; Pawlik TM
    J Am Coll Surg; 2013 Nov; 217(5):896-906. PubMed ID: 24041557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
    Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
    Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
    Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.
    Mittal S; Sada YH; El-Serag HB; Kanwal F; Duan Z; Temple S; May SB; Kramer JR; Richardson PA; Davila JA
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):594-601.e1. PubMed ID: 25148760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.
    El-Serag HB; Alsarraj A; Richardson P; Davila JA; Kramer JR; Durfee J; Kanwal F
    Dig Dis Sci; 2013 Nov; 58(11):3117-26. PubMed ID: 23868438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
    El-Serag HB; Kanwal F; Richardson P; Kramer J
    Hepatology; 2016 Jul; 64(1):130-7. PubMed ID: 26946190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of travel distance and rurality of residence on initial surveillance for hepatocellular carcinoma in VA primary care patient with cirrhosis.
    Rodriguez Villalvazo Y; McDanel JS; Beste LA; Sanchez AJ; Vaughan-Sarrazin M; Katz DA
    Health Serv Res; 2020 Feb; 55(1):103-112. PubMed ID: 31763691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
    Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
    J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.
    Ioannou GN; Beste LA; Green PK; Singal AG; Tapper EB; Waljee AK; Sterling RK; Feld JJ; Kaplan DE; Taddei TH; Berry K
    Gastroenterology; 2019 Nov; 157(5):1264-1278.e4. PubMed ID: 31356807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
    Davila JA; Duan Z; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.
    Rogal SS; Taddei TH; Monto A; Yakovchenko V; Patton H; Merante M; Spoutz P; Chia L; Yudkevich J; Aytaman A; Rabiee A; John BV; Blechacz B; Cai CX; Gilles H; Shah AS; McCurdy H; Puri P; Jou J; Mazhar K; Dominitz JA; Anwar J; Morgan TR; Ioannou GN
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):324-338. PubMed ID: 37460005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
    Pocha C; Knott A; Rector TS; Dieperink E
    J Clin Psychiatry; 2014 Oct; 75(10):e1122-6. PubMed ID: 25373121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma.
    Salami AC; Barden GM; Castillo DL; Hanna M; Petersen NJ; Davila JA; Naik AD; Anaya DA
    J Oncol Pract; 2015 Jan; 11(1):e66-74. PubMed ID: 25466708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.